200 related articles for article (PubMed ID: 38077322)
41. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.
Li P; Li J; Wen F; Cao Y; Luo Z; Zuo J; Wu F; Li Z; Li W; Wang F
Front Oncol; 2022; 12():966920. PubMed ID: 36276132
[TBL] [Abstract][Full Text] [Related]
42. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract][Full Text] [Related]
43. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
[TBL] [Abstract][Full Text] [Related]
44. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
Front Immunol; 2021; 12():695865. PubMed ID: 34135913
[TBL] [Abstract][Full Text] [Related]
45. The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia.
Yang J; Li L; Cheng J; Lu J; Zhang S; Wang S; Zhao L; Zhou L
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11457-11469. PubMed ID: 37391640
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
47. N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer.
Yu L; Wang L; Sun J; Zhou X; Hu Y; Hu L; He Y; Lin C; Chen J; Xu X; Dunlop MG; Theodoratou E; Ding K; Li X
Front Genet; 2023; 14():885930. PubMed ID: 36936424
[TBL] [Abstract][Full Text] [Related]
48. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
[TBL] [Abstract][Full Text] [Related]
49. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
Shi H; Gao L; Zhang W; Jiang M
BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
[TBL] [Abstract][Full Text] [Related]
50. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
51. Characterization of ligamentum flavum hypertrophy based on m6A RNA methylation modification and the immune microenvironment.
He Z; Zhu Z; Tang T; Guo P; Gao M; Li B; Nguyen TCT; Chen H; Liu X; Zhou Z; Liu S
Am J Transl Res; 2022; 14(12):8800-8827. PubMed ID: 36628248
[TBL] [Abstract][Full Text] [Related]
52. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
[TBL] [Abstract][Full Text] [Related]
53. Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia.
Song Y; Tian S; Zhang P; Zhang N; Shen Y; Deng J
Front Genet; 2021; 12():708699. PubMed ID: 35111195
[TBL] [Abstract][Full Text] [Related]
54. Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis.
Yan H; Qu J; Cao W; Liu Y; Zheng G; Zhang E; Cai Z
Cancer Immunol Immunother; 2019 Dec; 68(12):1971-1978. PubMed ID: 31650199
[TBL] [Abstract][Full Text] [Related]
55. Establishment and validation of a prognostic immune-related lncRNA risk model for acute myeloid leukemia.
Xie KY; Chen SZ; Wang Y; Zeng ML; Liu XY; Liang Y; Wei J
Transl Cancer Res; 2023 Dec; 12(12):3693-3702. PubMed ID: 38192996
[TBL] [Abstract][Full Text] [Related]
56. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma.
Tian L; Wang Y; Tian J; Song W; Li L; Che G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493
[TBL] [Abstract][Full Text] [Related]
57. Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes.
Jia E; Ren N; Guo B; Cui Z; Zhang B; Xue J
World J Surg Oncol; 2022 Feb; 20(1):59. PubMed ID: 35220962
[TBL] [Abstract][Full Text] [Related]
58. RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.
Fan J; Zhuang M; Fan W; Hou M
PeerJ; 2023; 11():e15706. PubMed ID: 37663284
[TBL] [Abstract][Full Text] [Related]
59. RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer.
Mu LX; Shao YC; Wei L; Chen FF; Zhang JW
Front Genet; 2021; 12():650499. PubMed ID: 35095993
[No Abstract] [Full Text] [Related]
60. Analysis of prognostic biomarker models and immune microenvironment in acute myeloid leukemia by integrative bioinformatics.
Wang N
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9609-9619. PubMed ID: 37222809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]